257 related articles for article (PubMed ID: 22991301)
21. Mineralization defects in cementum and craniofacial bone from loss of bone sialoprotein.
Foster BL; Ao M; Willoughby C; Soenjaya Y; Holm E; Lukashova L; Tran AB; Wimer HF; Zerfas PM; Nociti FH; Kantovitz KR; Quan BD; Sone ED; Goldberg HA; Somerman MJ
Bone; 2015 Sep; 78():150-64. PubMed ID: 25963390
[TBL] [Abstract][Full Text] [Related]
22. Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice.
Bowden SA; Foster BL
Adv Exp Med Biol; 2019; 1148():279-322. PubMed ID: 31482504
[TBL] [Abstract][Full Text] [Related]
23. Root development in mice lacking functional tissue non-specific alkaline phosphatase gene: inhibition of acellular cementum formation.
Beertsen W; VandenBos T; Everts V
J Dent Res; 1999 Jun; 78(6):1221-9. PubMed ID: 10371245
[TBL] [Abstract][Full Text] [Related]
24. Hypophosphatasia - pathophysiology and treatment.
Millán JL; Plotkin H
Actual osteol; 2012 Sep; 8(3):164-182. PubMed ID: 25254037
[TBL] [Abstract][Full Text] [Related]
25. Tissue-Nonspecific Alkaline Phosphatase-A Gatekeeper of Physiological Conditions in Health and a Modulator of Biological Environments in Disease.
Liedtke D; Hofmann C; Jakob F; Klopocki E; Graser S
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33302551
[TBL] [Abstract][Full Text] [Related]
26. The mechanism of mineralization and the role of alkaline phosphatase in health and disease.
Orimo H
J Nippon Med Sch; 2010 Feb; 77(1):4-12. PubMed ID: 20154452
[TBL] [Abstract][Full Text] [Related]
27. Gene Therapy Using Recombinant AAV Type 8 Vector Encoding TNAP-D
Amadeu de Oliveira F; Mohamed FF; Kinoshita Y; Narisawa S; Farquharson C; Miyake K; Foster BL; Millan JL
JBMR Plus; 2023 Jan; 7(1):e10709. PubMed ID: 36699639
[TBL] [Abstract][Full Text] [Related]
28. Biological stenciling of mineralization in the skeleton: Local enzymatic removal of inhibitors in the extracellular matrix.
Reznikov N; Hoac B; Buss DJ; Addison WN; Barros NMT; McKee MD
Bone; 2020 Sep; 138():115447. PubMed ID: 32454257
[TBL] [Abstract][Full Text] [Related]
29. Identification of altered brain metabolites associated with TNAP activity in a mouse model of hypophosphatasia using untargeted NMR-based metabolomics analysis.
Cruz T; Gleizes M; Balayssac S; Mornet E; Marsal G; Millán JL; Malet-Martino M; Nowak LG; Gilard V; Fonta C
J Neurochem; 2017 Mar; 140(6):919-940. PubMed ID: 28072448
[TBL] [Abstract][Full Text] [Related]
30. GSK3β rephosphorylation rescues ALPL deficiency-induced impairment of odontoblastic differentiation of DPSCs.
Zhang L; Zhao J; Dong J; Liu Y; Xuan K; Liu W
Stem Cell Res Ther; 2021 Apr; 12(1):225. PubMed ID: 33823913
[TBL] [Abstract][Full Text] [Related]
31. TNAP as a New Player in Chronic Inflammatory Conditions and Metabolism.
Graser S; Liedtke D; Jakob F
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477631
[TBL] [Abstract][Full Text] [Related]
32. Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity.
Addison WN; Azari F; Sørensen ES; Kaartinen MT; McKee MD
J Biol Chem; 2007 May; 282(21):15872-83. PubMed ID: 17383965
[TBL] [Abstract][Full Text] [Related]
33. Gene therapy improves dental manifestations in hypophosphatasia model mice.
Okawa R; Iijima O; Kishino M; Okawa H; Toyosawa S; Sugano-Tajima H; Shimada T; Okada T; Ozono K; Ooshima T; Nakano K
J Periodontal Res; 2017 Jun; 52(3):471-478. PubMed ID: 27561677
[TBL] [Abstract][Full Text] [Related]
34. Effects of Infantile Hypophosphatasia on Human Dental Tissue.
Wölfel EM; von Kroge S; Matthies L; Koehne T; Petz K; Beikler T; Schmid-Herrmann CU; Kahl-Nieke B; Tsiakas K; Santer R; Muschol NM; Herrmann J; Busse B; Amling M; Rolvien T; Jandl NM; Barvencik F
Calcif Tissue Int; 2023 Mar; 112(3):308-319. PubMed ID: 36414794
[TBL] [Abstract][Full Text] [Related]
35. Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(-/-) mice.
Harmey D; Johnson KA; Zelken J; Camacho NP; Hoylaerts MF; Noda M; Terkeltaub R; Millán JL
J Bone Miner Res; 2006 Sep; 21(9):1377-86. PubMed ID: 16939396
[TBL] [Abstract][Full Text] [Related]
36. What Can We Learn About the Neural Functions of TNAP from Studies on Other Organs and Tissues?
Millán JL
Subcell Biochem; 2015; 76():155-66. PubMed ID: 26219711
[TBL] [Abstract][Full Text] [Related]
37. Tributyltin alters osteocalcin, matrix metalloproteinase 20 and dentin sialophosphoprotein gene expression in mineralizing mouse embryonic tooth in vitro.
Salmela E; Alaluusua S; Sahlberg C; Lukinmaa PL
Cells Tissues Organs; 2012; 195(4):287-95. PubMed ID: 21778681
[TBL] [Abstract][Full Text] [Related]
38. Disruption of Wnt/β-catenin signaling in odontoblasts and cementoblasts arrests tooth root development in postnatal mouse teeth.
Zhang R; Yang G; Wu X; Xie J; Yang X; Li T
Int J Biol Sci; 2013; 9(3):228-36. PubMed ID: 23494738
[TBL] [Abstract][Full Text] [Related]
39. Tissue non-specific alkaline phosphatase activity and mineralization capacity of bi-allelic mutations from severe perinatal and asymptomatic hypophosphatasia phenotypes: Results from an in vitro mutagenesis model.
Uday S; Matsumura T; Saraff V; Saito S; Orimo H; Högler W
Bone; 2019 Oct; 127():9-16. PubMed ID: 31146036
[TBL] [Abstract][Full Text] [Related]
40. Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of Hypophosphatasia.
Tenorio J; Álvarez I; Riancho-Zarrabeitia L; Martos-Moreno GÁ; Mandrile G; de la Flor Crespo M; Sukchev M; Sherif M; Kramer I; Darnaude-Ortiz MT; Arias P; Gordo G; Dapía I; Martinez-Villanueva J; Gómez R; Iturzaeta JM; Otaify G; García-Unzueta M; Rubinacci A; Riancho JA; Aglan M; Temtamy S; Hamid MA; Argente J; Ruiz-Pérez VL; Heath KE; Lapunzina P
Am J Med Genet A; 2017 Mar; 173(3):601-610. PubMed ID: 28127875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
